Preprint · CC-BY
via bioRxiv
Distinctive associations between plasma p-tau181 levels and hippocampal subfield volume across the Alzheimer's disease continuum
biorxiv · 2025
Abstract
BackgroundPlasma p-tau181 is a promising diagnostic marker of Alzheimers disease (AD) pathology, reflecting amyloid accumulation, tau deposition, and downstream neurodegeneration that leads to cognitive impairment. However, the specificity of plasma p-tau181 to AD-related tau pathology remains unclear.
ObjectiveTo assess whether plasma p-tau181 is differentially associated with volumetric changes in distinct hippocampal subfields and whether they mediate the relationship between plasma p-tau181 and cognition across the AD continuum.
Methods213 participants with normal cognition (N=57), mild cognitive impairment (N=109), and AD (N=47) from the Alzheimers Disease Neuroimaging Initiative (ADNI) were included for cross-sectional analyses of hippocampal subfield volume that was quantified using the Automatic Segmentation of Hippocampal Subfields (ASHS) software. A subset (n=89) was evaluated for one-year longitudinal changes in hippocampal subfield volume.
ResultsHigher plasma p-tau181 levels (pg/mL) were associated with decreased volumes in the CA1 and dentate gyrus, bilaterally, and right entorhinal cortex (ps < 0.05). Additionally, volumes of these subfields partially mediated the relationship between plasma p-tau181 and ADNI memory and executive function composite scores. Baseline plasma p-tau181, however, did not predict longitudinal atrophy of hippocampal subfields across diagnostic groups.
ConclusionsPlasma p-tau181 is differentially associated with hippocampal subfields that are closely related to both age- and AD-related neurodegeneration. Elevated plasma p-tau181 levels may reflect tau accumulation, and volumetric changes in CA1 and DG may mediate the detrimental effect of tau pathology on cognition.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- bioRxiv
- DOI
- 10.1101/2025.01.27.635113
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
A., R., & H., O. (2025). Distinctive associations between plasma p-tau181 levels and hippocampal subfield volume across the Alzheimer's disease continuum. <em>biorxiv</em>. https://doi.org/10.1101/2025.01.27.635113
Vancouver
A. R, H. O. Distinctive associations between plasma p-tau181 levels and hippocampal subfield volume across the Alzheimer's disease continuum. biorxiv. 2025. doi:10.1101/2025.01.27.635113.
BibTeX
@unpublished{rich2025Distin,
title = {Distinctive associations between plasma p-tau181 levels and hippocampal subfield volume across the Alzheimer's disease continuum},
author = {Rich, A. and Oh, H.},
journal = {biorxiv},
year = {2025},
doi = {10.1101/2025.01.27.635113},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Alzheimer s & Dementia 2025
Open access · CC-BY
Age‐anchored genetic risk for Alzheimer’s disease is associated with markers of cerebrovascular disease, inflammation, and neurodegeneration in older adults without dementia
Alzheimer s & Dementia 2025
Open access · CC-BY
Age‐anchored genetic risk for Alzheimer's disease is associated with markers of cerebrovascular disease, inflammation, and neurodegeneration in older adults without dementia
Aging 2016
Open access · CC-BY
Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice
npj Aging 2026
Open access · CC-BY
Early mitophagy activation by Urolithin A prevents, but late activation does not reverse, age-related cognitive impairment
npj aging 2026
Open access · OA
Early mitophagy activation by Urolithin A prevents, but late activation does not reverse, age-related cognitive impairment.
Current Aging Science 2010
Citation only